Join Fund Library now and get free access to personalized features to help you manage your investments.
Sector Equity
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
|
Close (05-01-2024) |
$15.12 |
|---|---|
| Change |
$0.00
(0.00%)
|
| Open | - |
|---|---|
| Day Range | - - - |
| Volume | 0 |
As at March 31, 2024
As at March 31, 2024
As at February 29, 2024
Loading...
Loading...
Inception Return (February 24, 2022): -6.03%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -2.82% | -1.79% | 5.56% | -1.79% | -2.67% | -8.17% | - | - | - | - | - | - | - | - |
| Benchmark | 4.14% | 6.62% | 15.26% | 6.62% | 13.96% | 3.95% | 9.11% | 16.99% | 9.96% | 9.65% | 8.48% | 9.70% | 7.76% | 7.67% |
| Category Average | 1.75% | 21.53% | 21.53% | 10.46% | 26.42% | 7.93% | 5.18% | 15.21% | 11.07% | 11.30% | 11.63% | 12.17% | 10.44% | 11.78% |
| Category Rank | 182 / 198 | 185 / 197 | 176 / 193 | 185 / 197 | 160 / 177 | 144 / 159 | - | - | - | - | - | - | - | - |
| Quartile Ranking | 4 | 4 | 4 | 4 | 4 | 4 | - | - | - | - | - | - | - | - |
| Return % | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 2.01% | -0.07% | 0.72% | 2.90% | -5.22% | -7.92% | -10.26% | 9.41% | 9.46% | -5.45% | 6.89% | -2.82% |
| Benchmark | 2.90% | -4.95% | 3.36% | 2.58% | -1.37% | -3.33% | -3.21% | 7.48% | 3.91% | 0.55% | 1.82% | 4.14% |
10.57% (July 2022)
-11.82% (April 2022)
| Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | - | - | - | 0.15% |
| Benchmark | 10.55% | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% |
| Category Average | 17.30% | 16.21% | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | 4 |
| Category Rank | - | - | - | - | - | - | - | - | - | 130/ 168 |
0.15% (2023)
0.15% (2023)
| Name | Percent |
|---|---|
| US Equity | 75.30 |
| International Equity | 24.28 |
| Cash and Equivalents | 0.41 |
| Other | 0.01 |
| Name | Percent |
|---|---|
| Healthcare | 99.58 |
| Cash and Cash Equivalent | 0.43 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| North America | 75.72 |
| Europe | 20.46 |
| Asia | 3.83 |
| Other | -0.01 |
| Name | Percent |
|---|---|
| Illumina Inc | 3.35 |
| Beam Therapeutics Inc | 3.24 |
| Lonza Group AG | 3.24 |
| Moderna Inc | 3.19 |
| CRISPR Therapeutics AG | 3.04 |
| Thermo Fisher Scientific Inc | 3.03 |
| Twist Bioscience Corp | 2.99 |
| Vertex Pharmaceuticals Inc | 2.92 |
| Abbvie Inc | 2.88 |
| Sarepta Therapeutics Inc | 2.81 |
| Standard Deviation | - | - | - |
|---|---|---|---|
| Beta | - | - | - |
| Alpha | - | - | - |
| Rsquared | - | - | - |
| Sharpe | - | - | - |
| Sortino | - | - | - |
| Treynor | - | - | - |
| Tax Efficiency | - | - | - |
| Volatility | - | - | - |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | - | - | - | - |
| Beta | - | - | - | - |
| Alpha | - | - | - | - |
| Rsquared | - | - | - | - |
| Sharpe | - | - | - | - |
| Sortino | - | - | - | - |
| Treynor | - | - | - | - |
| Tax Efficiency | - | - | - | - |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | February 24, 2022 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | - |
| Currency | CAD |
| Distribution Frequency | Quarterly |
| Assets ($mil) | $5 |
| 52 Week High | $19.15 |
| 52 Week Low | $14.44 |
| Annual Dividend | $0.09 |
| Annual Yield | - |
| Index | - |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
| Exposure | - |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | No |
CDNA seeks to replicate, to the extent reasonably possible, the performance of a global biotechnology and genomics industry index, net of expenses. Currently, CDNA seeks to replicate the performance of the Solactive Global Genomics Immunology and Medical Revolution CAD Hedged Index NTR (the “Index”). The Index intends to track the performance of companies that have business operations in the global biotechnology and genomics industry using the ARTIS® classification system.
The investment strategy of each CI ETF is to invest in and hold, to the extent reasonably possible, the Constituent Securities of the applicable Index in substantially the same proportion as they are reflected in the applicable Index.
| Name | Start Date |
|---|---|
| CI Global Asset Management | 03-09-2022 |
| Fund Manager | CI Global Asset Management |
|---|---|
| Advisor | CI Global Asset Management |
| Custodian | CIBC Mellon Trust Company |
| Registrar | TSX Trust Company |
| Distributor | - |
| Auditor | Ernst & Young LLP |
| MER | 0.44% |
|---|---|
| Management Fee | 0.40% |
Join Fund Library now and get free access to personalized features to help you manage your investments.
Fund Library
